A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
New recommendations address evolving drug landscape and advancing testing technologies since original 2003 guidance.
National study finds 17% of patients request tests based on social media content, while 93% expect doctors to order tests upon request.
Multi-year agreement will provide clinical workflow software and laboratory support for GlycoKnow liquid biopsy test.
